FilingSEC EDGAR8-K
Sunshine Biopharma adjusts Series B warrant exercise price
· SEC accepted
StageAdjusted
Filing content
The exercise price of Series B Warrants was reduced to $1.2046 following recent common stock sales under an at-the-market offering.
AI summary of the filing. Please also check the source.Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…